Electrophoresis Chip Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

Electrophoresis Chip Market Overview

The electrophoresis chip market is poised for significant growth from 2025 to 2030, driven by advancements in microfluidics, increasing demand for point-of-care diagnostics, and the rising adoption of electrophoresis techniques in various industries. Electrophoresis chips are widely used in biomedicine, food safety, environmental monitoring, and other applications due to their ability to separate and analyze biomolecules with high precision and efficiency. The market is expected to grow at a compound annual growth rate (CAGR) of 6.8% during the forecast period, reaching a valuation of approximately $1.2 billion by 2030.

Market Size and Share Analysis

In 2025, the global electrophoresis chip market is projected to be valued at $850 million. By 2030, the market is anticipated to expand to $1.2 billion, driven by increasing demand for miniaturized and portable diagnostic devices. The market is segmented by product type, process, application, end-use, and region.

By Product Type

• Capillary Electrophoresis: Holds the largest market share at 45% in 2025, owing to its widespread use in DNA sequencing and protein analysis.
• On-chip Electrophoresis: Expected to grow at a CAGR of 8.2% from 2025 to 2030, driven by its application in point-of-care diagnostics and lab-on-a-chip technologies.

By Process

• Gel Electrophoresis: Accounts for 35% of the market share in 2025, primarily used in research laboratories.
• Microfluidic Electrophoresis: Expected to grow at a CAGR of 7.5%, driven by its high throughput and automation capabilities.

By Application

• Biomedicine: Dominates the market with a share of 50% in 2025, driven by applications in genomics, proteomics, and drug discovery.
• Food: Expected to grow at a CAGR of 6.2%, driven by increasing demand for food safety testing.
• Environmental Monitoring: Accounts for 15% of the market share, with growth driven by regulatory requirements for water and air quality testing.
• Others: Includes applications in forensics and material science, contributing 10% to the market.

By End-Use

• Research Laboratories: Hold the largest share at 40% in 2025, driven by the need for advanced analytical tools.
• Hospitals and Diagnostic Centers: Expected to grow at a CAGR of 7.8%, driven by the adoption of point-of-care diagnostics.
• Pharmaceutical and Biotechnology Companies: Account for 30% of the market share, driven by drug development and quality control applications.

By Region

• North America: Leads the market with a share of 35% in 2025, driven by advanced healthcare infrastructure and high R&D investments.
• Europe: Accounts for 28% of the market share, with growth driven by stringent regulatory standards.
• Asia-Pacific: Expected to grow at the highest CAGR of 9.5%, driven by increasing healthcare expenditure and rising demand for diagnostics.
• Rest of the World: Contributes 12% to the market, with growth driven by emerging economies.

Key Players and Competitive Landscape

The electrophoresis chip market is highly competitive, with key players focusing on product innovation, partnerships, and mergers to strengthen their market position. Major players include:

• Shimadzu: Holds a market share of 18% in 2025, driven by its advanced capillary electrophoresis systems.
• PerkinElmer: Accounts for 15% of the market share, with a strong focus on life sciences and diagnostics.
• Micronit: Expected to grow at a CAGR of 8.5%, driven by its innovative microfluidic solutions.
• Bio-Rad: Holds a market share of 12%, with a strong presence in protein analysis and genomics.
• Agilent: Accounts for 10% of the market share, driven by its comprehensive portfolio of electrophoresis products.
• MicruX Technologies: Expected to grow at a CAGR of 9.2%, driven by its focus on lab-on-a-chip technologies.
• BOE: A emerging player with a market share of 5%, focusing on cost-effective solutions for emerging markets.

Market Trends and Drivers

• Miniaturization and Portability: Increasing demand for portable and handheld electrophoresis devices is driving market growth.
• Automation and High Throughput: Adoption of automated electrophoresis systems is increasing, particularly in pharmaceutical and biotechnology companies.
• Point-of-Care Diagnostics: Rising demand for rapid and accurate diagnostic solutions is boosting the adoption of electrophoresis chips in hospitals and clinics.
• Regulatory Support: Stringent regulations for food safety and environmental monitoring are driving the demand for electrophoresis chips.

Market Challenges

• High Costs: The high cost of advanced electrophoresis systems may hinder market growth in developing regions.
• Technical Complexity: The complexity of microfluidic and on-chip electrophoresis systems may limit their adoption among small-scale laboratories.

Market News on Policy and Companies

• Regulatory Approvals: In 2025, Shimadzu received FDA approval for its new capillary electrophoresis system, enhancing its market position in North America.
• Strategic Partnerships: In 2025, PerkinElmer partnered with a leading diagnostic company to develop next-generation electrophoresis chips for point-of-care diagnostics.
• Product Launches: Micronit launched a new line of microfluidic electrophoresis chips in 2025, targeting the growing demand for lab-on-a-chip technologies.

Segment Forecasts (2025 - 2030)

• Capillary Electrophoresis: Expected to grow at a CAGR of 6.5%, driven by its widespread use in research and diagnostics.
• On-chip Electrophoresis: Projected to grow at a CAGR of 8.2%, driven by advancements in microfluidics and lab-on-a-chip technologies.
• Biomedicine: Expected to grow at a CAGR of 7.0%, driven by increasing applications in genomics and proteomics.
• Asia-Pacific: Expected to grow at the highest CAGR of 9.5%, driven by increasing healthcare expenditure and rising demand for diagnostics.

Conclusion

The electrophoresis chip market is set for robust growth from 2025 to 2030, driven by technological advancements, increasing demand for diagnostics, and regulatory support. Key players are focusing on innovation and strategic partnerships to capitalize on emerging opportunities. With a projected CAGR of 6.8%, the market is expected to reach $1.2 billion by 2030, offering significant growth potential for stakeholders across the value chain.